Completed PHASE4 INTERVENTIONAL 2-arm NCT03609892

Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy

Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy

Sponsor: Xijing Hospital of Digestive Diseases

Conditions Chronic Gastritis Gastric Cancer Gastric Ulcer Gastritis Helicobacter Pylori Infection

Interventions Amoxicillin Berberine Bismuth Esomeprazole Furazolidone Tetracycline

Updated 8 times since 2018 Last updated: Aug 28, 2019 Started: Aug 1, 2018 Primary completion: Aug 20, 2019 Completion: Aug 20, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Chronic Gastritis and Gastric Cancer, this trial is completed. The trial is conducted by Xijing Hospital of Digestive Diseases and has accumulated 8 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Sep 2020 — Jan 2021 [monthly]

Completed PHASE4
Sep 2019 — Sep 2020 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2019 — Sep 2019 [monthly]

Recruiting PHASE4
Nov 2018 — Jun 2019 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Aug 2018 — Nov 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xijing Hospital of Digestive Diseases

Data source: Xijing Hospital of Digestive Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China